New Content Available in LEARNMD
LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. Since its launch in fall 2024, we have been working continuously to develop and add new content for our members. We’re excited to share what’s new on LEARNMD in February 2025!
European Reference Network – Neuromuscular Disease (ERN EURO-NMD) educational webinars
We’re excited to share that we have established a collaborative agreement with the ERN EURO-NMD to share the extensive catalogue of ERN EURO-NMD educational webinars in the LEARNMD platform! Over 70 videos from ERN EURO-NMD are now available to watch, with additional webinars in the process of being added.
National Neuromuscular Lecture Series
The weekly National Neuromuscular Lecture Series (NNLS) is our year-long CPD-accredited curriculum for neuromuscular fellows, containing 41 topics which constitute a comprehensive base of neuromuscular knowledge, with a weekly lecture presented by subject-matter experts on each topic. We have been working with speakers to allow these talks to be added to LEARNMD and are pleased to share that NNLS lectures from January 2025 will be available on the platform!
Multi-Disciplinary Care in NMDs lecture series
The Multi-Disciplinary Care of Neuromuscular Diseases lecture series is a new 24-topic CPD-accredited webinar series from the NMD4C, designed as an advanced curriculum for neurologists, physiatrists and neuromuscular fellows to learn fundamentals of multi-disciplinary care for patients across a range of neuromuscular conditions. We have been working with speakers to allow these talks to be added to LEARNMD and are pleased to share that all lectures in the series will be available on the platform!
Monthly Neuromuscular Educational Webinars
We continue to share our CPD-accredited monthly educational webinars on LEARNMD, with recordings of each monthly talk available soon after the presentation date. (The specialized quarterly Neuromuscular Mystery Case Rounds webinars are not available on LEARNMD.)
We hope that you take advantage of these training and learning resources on LEARNMD. The platform is available to all clinicians and researchers who are members of the NMD4C. Instructions on how to log in or create your LEARNMD account are available here.
All three of our National Neuromuscular Lecture Series, Multi-Disciplinary Care in NMDs lecture series, and Monthly Neuromuscular Educational Webinars are self-approved group learning activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. Certificates of attendance can only be issued for attending live – check out our list of upcoming webinars and register to join us at future live sessions!
For any questions about LEARNMD or the content, please contact our Curriculum and Education Coordinator.
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.